Who
Vincent Capponi
President and COO
Company insider
Files Form 4 as: President and COO, Cytosorbents.
In numbers
- Trades disclosed
- 126
- Buys
- 6
- Sells
- 16
- Bought
- $80K
- Sold
- $1.4M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 31 Dec 2006
- Last trade
- 14 Sep 2026
- Last filed
- 16 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Sep 2026filed 16 Sep 2026 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Bought | $11K1,800 at $6.07 | filing |
| 14 Sep 2026filed 16 Sep 2026 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Bought | $1,611273 at $5.90 | filing |
| 14 Sep 2026filed 16 Sep 2026 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Bought | $11K1,800 at $6.07 | filing |
| 14 Sep 2026filed 16 Sep 2026 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Bought | $1,611273 at $5.90 | filing |
| 8 Aug 2025filed 8 Aug 2025 | CTSO Cytosorbentsoption or derivative · Medical Devices | SEC FORM 4 Code A | —111,100 at $0.00 | filing |
| 8 Aug 2025filed 8 Aug 2025 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Code A | —89,100 at $0.00 | filing |
| 24 Feb 2025filed 26 Feb 2025 | CTSO Cytosorbentsoption or derivative · Medical Devices | SEC FORM 4 Code O | $14K12,000 at $1.13 | filing |
| 24 Feb 2025filed 26 Feb 2025 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Code O | $14K12,000 at $1.13 | filing |
| 17 Jan 2025filed 22 Jan 2025 | CTSO Cytosorbentsoption or derivative · Medical Devices | SEC FORM 4 Code X | —31,760 at $0.00 | filing |
| 17 Jan 2025filed 22 Jan 2025 | CTSO Cytosorbentsoption or derivative · Medical Devices | SEC FORM 4 Code J | —31,760 | filing |
| 17 Jan 2025filed 22 Jan 2025 | CTSO Cytosorbentsoption or derivative · Medical Devices | SEC FORM 4 Code J | —31,760 | filing |
| 17 Jan 2025filed 22 Jan 2025 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Code X | $32K31,760 at $1.00 | filing |
| 4 Oct 2024filed 8 Oct 2024 | CTSO Cytosorbentsoption or derivative · Medical Devices | SEC FORM 4 Code A | —100,000 | filing |
| 4 Oct 2024filed 8 Oct 2024 | CTSO Cytosorbentsoption or derivative · Medical Devices | SEC FORM 4 Code A | —50,000 | filing |
| 2 Apr 2024filed 4 Apr 2024 | CTSO Cytosorbentsoption or derivative · Medical Devices | SEC FORM 4 Code A | —101,000 | filing |
| 2 Apr 2024filed 4 Apr 2024 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Code A | —81,000 at $0.00 | filing |
| 29 Mar 2024filed 2 Apr 2024 | CTSO Cytosorbentsoption or derivative · Medical Devices | SEC FORM 4 Code A | —48,923 | filing |
| 13 Dec 2023filed 15 Dec 2023 | CTSO Cytosorbentsoption or derivative · Medical Devices | SEC FORM 4 Code P | —6,578 | filing |
| 13 Dec 2023filed 15 Dec 2023 | CTSO CytosorbentsMedical Devices | SEC FORM 4 Bought | $25K18,797 at $1.33 | filing |
| 7 Jul 2023filed 11 Jul 2023 | CTSO Cytosorbentsoption or derivative · Medical Devices | SEC FORM 4 Code A | —91,000 at $0.00 | filing |
News
Critical Survey: Cytosorbents (NASDAQ:CTSO) & Trinity Biotech (NASDAQ:TRIB)CTSO · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name Vincent Capponi; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.